Ibudilast extended-release tablets

This product has an inhibitory effect on the contraction of airway smooth muscle of isolated animals caused by inflammatory mediators such as leukotriene D4 (LTD4) and platelet activating factor (PAF); it can relieve the spasm of airway smooth muscle of guinea pigs caused by inflammatory mediators, and can inhibit passive skin allergic reactions in experimental animals.

The main ingredient of this product is ibudilast. Its chemical name is 2-methyl-1-[2-(1-methylethyl)pyrazolin[1,5-a]pyridin-3-yl]-1-propanone.

This product is a white tablet.

Used for the treatment of mild and moderate bronchial asthma.

Oral administration: Swallow the whole tablet without chewing, twice a day, 1 tablet each time.

The main symptoms are loss of appetite, belching, upper abdominal discomfort, nausea, vomiting, dizziness, rash, skin itching, etc. Occasionally, palpitations, serum glutamate oxaloacetate transaminase (S-GOT), serum glutamate pyruvate transaminase (S-GPT), γ-glutamyl transpeptidase (γ-GT), and total bilirubin are increased. Most of these adverse reactions are tolerable. Orthostatic hypotension is rare.

1. Patients who are allergic to this product are contraindicated. 2. Patients whose intracranial hemorrhage has not been completely controlled are contraindicated.

Not yet clear.

Store at room temperature.

10 mg

Sichuan Yang Tian Biopharmaceutical Co., Ltd.

• Founded in:

  1993-08-16

• Address:

  No. 39, Baiye Road, High-tech West District, Chengdu

• Tax NO.:

  915100006216084145

• Registered Funds:

  50 million yuan

• Website:

  Log in to view

• Email:

  Log in to view